FI86991B - Rekombinant-dna-sekvenser, deras framstaellning och dessa sekvenser innehaollande plasmider. - Google Patents

Rekombinant-dna-sekvenser, deras framstaellning och dessa sekvenser innehaollande plasmider.

Info

Publication number
FI86991B
FI86991B FI834700A FI834700A FI86991B FI 86991 B FI86991 B FI 86991B FI 834700 A FI834700 A FI 834700A FI 834700 A FI834700 A FI 834700A FI 86991 B FI86991 B FI 86991B
Authority
FI
Finland
Prior art keywords
sequentor
plasmider
derase
innehaollande
recombinant dna
Prior art date
Application number
FI834700A
Other languages
English (en)
Other versions
FI834700A (fi
FI86991C (fi
FI834700A0 (fi
Inventor
Marc-Bruce Dworkin
Eva Dworkin-Rastl
Gynther Adolf
Norbert Hauel
Peter Meindl
Peter Swetly
Rudolf Hauptmann
Original Assignee
Boehringer Ingelheim Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int
Publication of FI834700A0 publication Critical patent/FI834700A0/fi
Publication of FI834700A publication Critical patent/FI834700A/fi
Publication of FI86991B publication Critical patent/FI86991B/fi
Application granted granted Critical
Publication of FI86991C publication Critical patent/FI86991C/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70—Vectors or expression systems specially adapted for E. coli
    • C12N15/71—Expression systems using regulatory sequences derived from the trp-operon
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/555—Interferons [IFN]
    • C07K14/56—IFN-alpha
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/66—General methods for inserting a gene into a vector to form a recombinant vector using cleavage and ligation; Use of non-functional linkers or adaptors, e.g. linkers containing the sequence for a restriction endonuclease
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/67—General methods for enhancing the expression
    • C12N15/68—Stabilisation of the vector

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Toxicology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
FI834700A 1982-12-24 1983-12-21 Rekombinant-dna-sekvenser, deras framstaellning och dessa sekvenser innehaollande plasmider FI86991C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3247922 1982-12-24
DE19823247922 DE3247922A1 (de) 1982-12-24 1982-12-24 Dna-sequenzen, deren herstellung, diese sequenzen enthaltende plasmide und deren verwendung zur synthese eukaryotischer genprodukte in prokaryoten

Publications (4)

Publication Number Publication Date
FI834700A0 FI834700A0 (fi) 1983-12-21
FI834700A FI834700A (fi) 1984-06-25
FI86991B true FI86991B (fi) 1992-07-31
FI86991C FI86991C (fi) 1992-11-10

Family

ID=6181687

Family Applications (1)

Application Number Title Priority Date Filing Date
FI834700A FI86991C (fi) 1982-12-24 1983-12-21 Rekombinant-dna-sekvenser, deras framstaellning och dessa sekvenser innehaollande plasmider

Country Status (19)

Country Link
EP (1) EP0115613B1 (fi)
JP (2) JPH088868B2 (fi)
KR (1) KR930005455B1 (fi)
AT (1) ATE62018T1 (fi)
AU (1) AU579991B2 (fi)
DD (1) DD216043A5 (fi)
DE (2) DE3247922A1 (fi)
DK (1) DK576983A (fi)
ES (4) ES528350A0 (fi)
FI (1) FI86991C (fi)
GR (1) GR78766B (fi)
HU (1) HU202277B (fi)
IL (1) IL70523A (fi)
MX (1) MX9202878A (fi)
NO (1) NO173742C (fi)
NZ (1) NZ206700A (fi)
SU (2) SU1366064A3 (fi)
UA (1) UA8035A1 (fi)
ZA (1) ZA839519B (fi)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3584198D1 (de) * 1984-08-01 1991-10-31 Boehringer Ingelheim Int Neue genetische sequenzen, die durch sie codierten interferon-peptide vom typ i und diese sie produzierende organismen.
US6291662B1 (en) 1984-12-05 2001-09-18 Amgen Inc. Recombinant methods for production of serine protease inhibitors and DNA sequences
ATE108205T1 (de) * 1984-12-06 1994-07-15 Synergen Biolog Inc Rekombinantverfahren zur herstellung von serinproteaseinhibitoren, sowie dns-sequenzen dazu.
FI90990C (fi) * 1984-12-18 1994-04-25 Boehringer Ingelheim Int Rekombinantti-DNA-molekyyli, transformoitu isäntäorganismi ja menetelmä interferonin valmistamiseksi
DK156072C (da) * 1985-04-03 1989-11-06 Nordisk Gentofte Syntetisk dna-sekvens indeholdende et ribosombindingssted
DK151585D0 (da) * 1985-04-03 1985-04-03 Nordisk Gentofte Dna-sekvens
DE3514113A1 (de) * 1985-04-19 1986-10-23 Hoechst Ag, 6230 Frankfurt Veraenderung der dna-sequenz zwischen shine-dalgarno-sequenz und startcodon des trp-operons zur steigerung der proteinexpression
US4874703A (en) * 1985-08-26 1989-10-17 Eli Lilly And Company Expression vectors for use in E. coli
DE3607835A1 (de) * 1986-03-10 1987-09-24 Boehringer Ingelheim Int Hybridinterferone, deren verwendung als arzneimittel und als zwischenprodukte zur herstellung von antikoerpern und deren verwendung sowie verfahren zu ihrer herstellung
DE3642096A1 (de) * 1986-12-10 1988-06-16 Boehringer Ingelheim Int Pferde-(gamma)-interferon
GB8813032D0 (en) * 1988-06-02 1988-07-06 Boehringer Ingelheim Int Antiviral pharmaceutical composition
AU4315089A (en) * 1988-11-04 1990-05-28 Upjohn Company, The Somatotropin expression using a serratia promoter
EP0626448A3 (de) * 1993-05-26 1998-01-14 BOEHRINGER INGELHEIM INTERNATIONAL GmbH Verfahren zur Herstellung und Reinigung von alpha-Interferon
US5531880A (en) * 1994-09-13 1996-07-02 Microelectronics And Computer Technology Corporation Method for producing thin, uniform powder phosphor for display screens
FR2724665B1 (fr) * 1994-09-16 1996-12-20 Rhone Poulenc Rorer Sa Procede de production de proteines recombinantes, plasmides et cellules modifiees

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA811368B (en) * 1980-03-24 1982-04-28 Genentech Inc Bacterial polypedtide expression employing tryptophan promoter-operator
ATE25985T1 (de) * 1980-06-12 1987-04-15 Japan Found Cancer Plasmid.
ZA814375B (en) * 1980-07-01 1982-07-28 Hoffmann La Roche Interferons and process for their preparation
IE52755B1 (en) * 1980-08-26 1988-02-17 Univ California Bovine pre-growth and growth hormone
DE3280127D1 (de) * 1981-03-27 1990-04-12 Ici Plc Genetisch modifizierte mikroorganismen.
DE3220116A1 (de) * 1982-05-28 1983-12-01 Dr. Karl Thomae Gmbh, 7950 Biberach Mikrobiologisch hergestellte (alpha)- und ss-interferone, dna-sequenzen, die fuer diese interferone codieren, mikroorganismen, die diese genetische information enthalten, und verfahren zu ihrer herstellung
DE3247923A1 (de) * 1982-12-24 1984-06-28 Dr. Karl Thomae Gmbh, 7950 Biberach Neue oligonucleotide und verfahren zu ihrer herstellung

Also Published As

Publication number Publication date
MX9202878A (es) 1992-06-30
DD216043A5 (de) 1984-11-28
DE3382233D1 (de) 1991-05-02
IL70523A (en) 1991-08-16
KR930005455B1 (ko) 1993-06-22
SU1366064A3 (ru) 1988-01-07
EP0115613A3 (en) 1986-07-23
ES8506090A1 (es) 1985-06-16
DK576983A (da) 1984-06-25
UA8035A1 (uk) 1995-12-26
KR840007105A (ko) 1984-12-05
HU202277B (en) 1991-02-28
ZA839519B (en) 1985-08-28
JP2637328B2 (ja) 1997-08-06
FI834700A (fi) 1984-06-25
NO834792L (no) 1984-06-25
ES533197A0 (es) 1985-02-16
NO173742B (no) 1993-10-18
JPH05214000A (ja) 1993-08-24
ES8501798A1 (es) 1984-12-01
EP0115613B1 (de) 1991-03-27
FI86991C (fi) 1992-11-10
JPH088868B2 (ja) 1996-01-31
ES8504930A1 (es) 1985-04-16
DE3247922A1 (de) 1984-06-28
JPS59162888A (ja) 1984-09-13
NZ206700A (en) 1987-11-27
GR78766B (fi) 1984-10-02
ES533213A0 (es) 1985-06-16
ES8503372A1 (es) 1985-02-16
SU1417800A3 (ru) 1988-08-15
NO173742C (no) 1994-01-26
AU579991B2 (en) 1988-12-22
EP0115613A2 (de) 1984-08-15
DK576983D0 (da) 1983-12-14
ES528350A0 (es) 1984-12-01
IL70523A0 (en) 1984-03-30
ATE62018T1 (de) 1991-04-15
AU2283283A (en) 1984-06-28
FI834700A0 (fi) 1983-12-21
ES533214A0 (es) 1985-04-16

Similar Documents

Publication Publication Date Title
FI86991B (fi) Rekombinant-dna-sekvenser, deras framstaellning och dessa sekvenser innehaollande plasmider.
Taniguchi et al. Expression of the human fibroblast interferon gene in Escherichia coli.
EP0042246B1 (en) Plasmid
ES8207514A1 (es) Un procedimiento para la preparacion de interferon
DK305885A (da) Tumornecrosefaktor og derivater og mutantformer deraf, frem. til frems. deraf, frem. til isolering deraf fra en blanding med andre proteiner,praeparater deraf, dna som koder derfor, dna'en inkorporeret i en replicerbar vektor og celle transformeret dermed
ES2122257T3 (es) Proteinas de fusion de la toxina del antrax y usos de las mismas.
DK440083A (da) Dna-sekvenser, rekombinations-dna-molekyler samt fremgangsmaader til fremstilling af svinevaeksthormonlignende polypeptider
ES8603574A1 (es) "procedimiento de tecnologia genetica para preparar secuen- cias parciales del gamma-interferon de humano".
SE8703539L (sv) Artificiell gen och proteinprodukt
IL81018A (en) Fusion proteins comprising small fragments of human interleukin-2 as ballast,process for its preparation and genes,vectors and transformed host containing said fragments and used in the process
FI971100A0 (fi) Menetelmä yhdistelmä-DNA-proteiinien, plasmidien ja modifioitujen solujen tuottamiseksi
ATE163651T1 (de) Neues menschliches, rekombinantes interferon gamma
DE3671916D1 (de) Mit einem herpes-simplex-virus-gen inseriertes rekombinantes plasmid.
EP0072541A3 (en) Human leukocyte interferons, process for their microbial production, intermediates therefor and compositions containing them
ES2071108T3 (es) Metodo eficiente para expresion identificable de genes no seleccionables.
NO910331L (no) Rekombinant plasmid, fremgangsmaate til dets fremstilling og anvendelse av plasmidet i produksjonen av proteiner.

Legal Events

Date Code Title Description
MM Patent lapsed
MM Patent lapsed

Owner name: BOEHRINGER INGELHEIM INTERNATIONAL GMBH